# Botulinum Toxin (BOTOX) for Cerebral Palsy

> **NCT00060957** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 40 (—)

## Conditions studied

- Cerebral Palsy
- Muscle Spasticity

## Interventions

- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT00060957
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-07
- **Primary completion:** 2002-06
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2016-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060957, "Botulinum Toxin (BOTOX) for Cerebral Palsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00060957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*